⌘K
Loading ticker…
HCW Biologics Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, HCW Biologics Inc. Common Stock (HCWB) has a 3-month relative strength percentile of 98 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 60. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 13.9%, relative volume 0.32×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 98, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
HCWB is in a stage 4 downtrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -3.9% / -41.6%.
Strong relative strength with attention running hot versus its own recent norm. The trend is intact but well-noticed; elevated retail attention has historically been associated with softer forward returns. Context, not a call.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
HCWB appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $4K notional.
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $4K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | HCWB Jan avg: -7.02% median: -2.40% win: 50% σ: 22.10% n: 4 2022-04-12 → 2026-05-29 | HCWB Feb avg: 1.49% median: 10.30% win: 50% σ: 39.97% n: 4 2022-04-12 → 2026-05-29 | HCWB Mar avg: -15.58% median: -23.98% win: 25% σ: 23.56% n: 4 2022-04-12 → 2026-05-29 | HCWB Apr avg: -8.33% median: -20.00% win: 40% σ: 25.00% n: 5 2022-04-12 → 2026-05-29 | HCWB May avg: 56.87% median: -4.09% win: 40% σ: 147.47% n: 5 2022-04-12 → 2026-05-29 | HCWB Jun avg: -8.48% median: -17.44% win: 50% σ: 45.59% n: 4 2022-04-12 → 2026-05-29 (current) | HCWB Jul avg: 0.72% median: 0.47% win: 50% σ: 8.19% n: 4 2022-04-12 → 2026-05-29 | HCWB Aug avg: 1.85% median: -1.94% win: 50% σ: 25.46% n: 4 2022-04-12 → 2026-05-29 | HCWB Sep avg: -6.03% median: -2.90% win: 50% σ: 22.60% n: 4 2022-04-12 → 2026-05-29 | HCWB Oct avg: -7.32% median: -6.88% win: 25% σ: 10.80% n: 4 2022-04-12 → 2026-05-29 | HCWB Nov avg: -19.30% median: -20.74% win: 25% σ: 25.52% n: 4 2022-04-12 → 2026-05-29 | HCWB Dec avg: -13.89% median: -7.39% win: 25% σ: 28.66% n: 4 2022-04-12 → 2026-05-29 |